| Lactose (India) Ltd | 159 Cr. | 126 | 247/84.3 | 35.2 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,872 Cr. | 447 | 479/192 | 101 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.9 Cr. | 44.3 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 38.6 Cr. | 26.4 | 29.1/17.0 | 91.9 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 61.5 Cr. | 81.7 | 134/78.3 | 16.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 52,741 Cr. | 1,869 | 2,286/1,275 | 21.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 347 Cr. | 15.0 | 19.9/10.8 | 20.8 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 886 Cr. | 1,877 | 1,877/635 | 30.7 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 109 Cr. | 21.9 | 32.0/15.5 | 29.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 815 Cr. | 277 | 449/219 | 7.27 | 133 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 10.2 Cr. | 4.09 | 9.28/2.11 | 5.78 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 435 Cr. | 448 | 477/117 | 65.7 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,944 Cr. | 1,136 | 1,565/1,038 | 44.7 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 61.4 Cr. | 0.30 | 1.24/0.26 | 4.04 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 43.2 Cr. | 18.0 | 26.3/6.54 | 44.6 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.7 Cr. | 10.6 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 181 Cr. | 507 | 859/443 | 10.3 | 596 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 86.8 Cr. | 86.8 | 92.5/26.1 | 164 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,716 Cr. | 1,502 | 2,452/1,345 | 48.9 | 174 | 0.71 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.2 Cr. | 44.1 | 88.7/36.1 | 43.8 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 16.7 Cr. | 6.69 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.8 Cr. | 112 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 45.5 Cr. | 83.1 | 83.1/9.41 | 31.4 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.1 Cr. | 40.0 | 80.0/0.00 | 48.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 7.31 Cr. | 24.4 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,086 Cr. | 581 | 1,028/492 | 28.6 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.9 Cr. | 20.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.0 Cr. | 23.8 | 43.7/17.4 | 52.4 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 92,747 Cr. | 2,247 | 3,055/2,115 | 55.7 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 236 Cr. | 409 | 524/241 | 24.2 | 123 | 1.10 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 45.4 Cr. | 31.6 | 62.6/26.7 | 71.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 72,475 Cr. | 1,237 | 1,365/994 | 21.2 | 598 | 0.32 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 141 Cr. | 226 | 303/159 | 134 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 803 Cr. | 80.1 | 123/74.0 | 20.7 | 32.6 | 1.87 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.5 Cr. | 29.5 | 50.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,995 Cr. | 1,709 | 1,868/919 | 62.5 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.90 Cr. | 0.59 | 1.45/0.55 | 97.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 234 Cr. | 30.5 | 68.0/30.0 | 15.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 6.52 Cr. | 11.2 | 23.8/9.40 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 127 Cr. | 5.40 | 6.57/2.82 | 296 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,815 Cr. | 29,560 | 37,000/25,260 | 41.6 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,608 Cr. | 729 | 972/550 | 27.6 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 275 Cr. | 97.0 | 100/31.3 | 76.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,788 Cr. | 1,578 | 1,633/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,234 Cr. | 1,368 | 1,870/1,110 | 405 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 848 Cr. | 243 | 330/154 | 19.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 742 Cr. | 555 | 590/270 | 11.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,357 Cr. | 477 | 908/438 | 23.0 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,604 Cr. | 1,135 | 1,595/991 | 22.7 | 768 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,260 Cr. | 3,819 | 3,882/2,886 | 59.7 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,066 Cr. | 116 | 310/98.0 | | 41.3 | 0.43 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,559 Cr. | 16.6 | 24.0/14.1 | 24.8 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 23,392 Cr. | 611 | 1,360/609 | 68.1 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,121 Cr. | 181 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,23,219 Cr. | 1,764 | 1,910/1,547 | 36.7 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,563 Cr. | 575 | 886/441 | 400 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,718 Cr. | 290 | 329/175 | 33.5 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 393 Cr. | 1,301 | 1,680/956 | 21.0 | 683 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,331 Cr. | 375 | 502/265 | 47.4 | 125 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,847 Cr. | 231 | 242/111 | 135 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,626 Cr. | 4,614 | 6,718/4,146 | 28.8 | 340 | 2.54 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,821 Cr. | 2,310 | 2,725/1,772 | 34.3 | 335 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,819 Cr. | 5,916 | 6,739/4,904 | 32.0 | 373 | 2.11 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 169 Cr. | 47.8 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,155 Cr. | 5,062 | 5,993/3,701 | 32.8 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 116 Cr. | 94.1 | 348/81.0 | 12.0 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,388 Cr. | 390 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,353 Cr. | 858 | 1,998/604 | 83.3 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,268 Cr. | 17,356 | 19,748/10,060 | 114 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 327 Cr. | 14.6 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,703 Cr. | 821 | 1,505/660 | 9.56 | 483 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,536 Cr. | 46.3 | 91.7/41.7 | 33.6 | 21.8 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,830 Cr. | 195 | 359/162 | 25.1 | 59.3 | 0.41 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 98.1 Cr. | 61.2 | 130/58.6 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 306 Cr. | 86.0 | 177/85.5 | 150 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 93,741 Cr. | 2,052 | 2,403/1,774 | 21.7 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,068 Cr. | 533 | 980/490 | 13.4 | 357 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 55,226 Cr. | 1,022 | 1,025/475 | 80.9 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 986 Cr. | 950 | 1,235/596 | 20.1 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 147 Cr. | 67.3 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 675 Cr. | 139 | 236/139 | 38.3 | 104 | 2.15 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 622 Cr. | 356 | 500/265 | 22.6 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 18,501 Cr. | 1,159 | 1,265/802 | 37.2 | 414 | 0.43 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,502 Cr. | 1,822 | 1,952/1,303 | 39.7 | 243 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,400 Cr. | 210 | 328/193 | 32.0 | 38.0 | 1.19 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,792 Cr. | 1,465 | 1,758/1,168 | 37.2 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,806 Cr. | 95.7 | 127/57.5 | 24.2 | 59.7 | 0.84 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 811 Cr. | 99.6 | 124/67.2 | 27.4 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,409 Cr. | 260 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,878 Cr. | 234 | 465/225 | 285 | 96.9 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,425 Cr. | 1,666 | 2,768/1,243 | 32.5 | 397 | 0.42 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,160 Cr. | 313 | 498/285 | 58.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,662 Cr. | 562 | 628/412 | 26.7 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 52,688 Cr. | 1,869 | 2,286/1,275 | 21.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,260 Cr. | 2,493 | 3,516/1,921 | 44.3 | 101 | 1.68 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 29,894 Cr. | 1,815 | 2,131/1,200 | 25.8 | 610 | 0.99 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,715 Cr. | 413 | 530/359 | 29.8 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,342 Cr. | 1,566 | 1,910/1,097 | 51.3 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,947 Cr. | 1,244 | 1,406/1,020 | 18.0 | 432 | 0.64 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,949 Cr. | 252 | 322/178 | 26.4 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,24,078 Cr. | 1,536 | 1,673/1,310 | 22.8 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,780 Cr. | 1,943 | 2,641/1,551 | 25.1 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 303 Cr. | 103 | 203/95.6 | 21.7 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,725 Cr. | 163 | 191/105 | 15.7 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.4 Cr. | 39.7 | 72.0/37.7 | 22.6 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 56,300 Cr. | 421 | 423/291 | 119 | 200 | 0.12 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,670 Cr. | 1,654 | 2,190/1,430 | 36.9 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 128 Cr. | 80.2 | 141/76.3 | 18.7 | 49.2 | 1.50 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 419 Cr. | 178 | 205/67.8 | 39.7 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,845 Cr. | 9,140 | 10,691/6,220 | 98.8 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,061 Cr. | 712 | 843/544 | 36.4 | 118 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 169 Cr. | 80.2 | 137/79.0 | 8.98 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,402 Cr. | 5,723 | 5,868/4,492 | 29.1 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,677 Cr. | 949 | 1,124/725 | 29.4 | 271 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 467 Cr. | 815 | 1,540/763 | | 690 | 0.61 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,286 Cr. | 2,504 | 3,116/2,022 | 32.1 | 345 | 1.12 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,770 Cr. | 338 | 412/258 | 25.6 | 133 | 1.54 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,253 Cr. | 463 | 575/312 | 22.3 | 146 | 0.22 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,386.93 Cr | 1,192.94 | | 53.65 | 202.19 | 0.34% | 16.24% | 14.95% | 6.10 |